Prognosis and survival analysis of patients with pancreatic cancer: retrospective experience of a single institution

[1] Chen W(2015)Cancer statistics: updated cancer burden in China Chin J Cancer Res 27 1-2921

[2] Rahib L(2014)Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States Cancer Res 74 2913-914

[3] Smith BD(2016)Recent trends in survival of patients with pancreatic cancer in germany and the United States Pancreas 45 908-1163

[4] Aizenberg R(2013)Modest improvement in overall survival for patients with metastatic pancreatic cancer: a trend analysis using the surveillance, epidemiology, and end results registry from 1988 to 2008 Pancreas 42 1157-270

[5] Rosenzweig AB(2006)1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience J Gastrointest Surg 10 discussion 210-1-2668

[6] Fleshman JM(2000)Survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas Chir Ital 52 263-4801

[7] Matrisian LM(2016)Locally advanced, unresectable pancreatic cancer: american society of clinical oncology clinical practice guideline J Clin Oncol 34 2654-1825

[8] Sirri E(2015)Metastatic pancreatic cancer: Is there a light at the end of the tunnel? World J Gastroenterol 21 4788-1703

[9] Castro FA(2011)FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer N Engl J Med 364 1817-1061

[10] Kieschke J(2013)Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine N Engl J Med 369 1691-591

[1] Chen W(2015)Cancer statistics: updated cancer burden in China Chin J Cancer Res 27 1-2921

[2] Rahib L(2014)Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States Cancer Res 74 2913-914

[3] Smith BD(2016)Recent trends in survival of patients with pancreatic cancer in germany and the United States Pancreas 45 908-1163

[4] Aizenberg R(2013)Modest improvement in overall survival for patients with metastatic pancreatic cancer: a trend analysis using the surveillance, epidemiology, and end results registry from 1988 to 2008 Pancreas 42 1157-270

[5] Rosenzweig AB(2006)1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience J Gastrointest Surg 10 discussion 210-1-2668

[6] Fleshman JM(2000)Survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas Chir Ital 52 263-4801

[7] Matrisian LM(2016)Locally advanced, unresectable pancreatic cancer: american society of clinical oncology clinical practice guideline J Clin Oncol 34 2654-1825

[8] Sirri E(2015)Metastatic pancreatic cancer: Is there a light at the end of the tunnel? World J Gastroenterol 21 4788-1703

[9] Castro FA(2011)FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer N Engl J Med 364 1817-1061

[10] Kieschke J(2013)Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine N Engl J Med 369 1691-591